CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborators:

Clinical Trials Promoting Group (APRIC/CTPG)

Gruppo Oncologico del Lazio (GOL)

Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente

Gruppo Oncologico Italiano di Ricerca Clinica(GOIRC)

Gruppo Oncologico Italia Meridionale

Northwest Oncology Cooperative Group(GONO)

Information provided by (Responsible Party):

National Cancer Institute, Naples

ClinicalTrials.gov Identifier:

NCT00526643

First received: September 6, 2007

Last updated: July 11, 2012

Last verified: July 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	September 2012
Primary Completion Date:	July 2012 (Final data collection date for primary outcome measure)